Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Biochemical Pharmacology|May 8, 2021
Can non-cholesterol sterols indicate the presence of specific dysregulation of cholesterol metabolism in patients with colorectal cancer?Sandra Vladimirov, Tamara Gojkovic, Aleksandra Zeljkovic, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 19, 2011
Characteristics of low-density and high-density lipoprotein subclasses in pediatric renal transplant recipientsAleksandra Zeljkovic, Jelena Vekic, Vesna Spasojevic-Kalimanovska, et al.
Biochemia Medica|November 16, 2018
Significance of LDL and HDL subclasses characterization in the assessment of risk for colorectal cancer developmentMilica Stevanovic, Jelena Vekic, Natasa Bogavac-Stanojevic, et al.
Lipids in Health and Disease|March 12, 2010
Evaluation of different formulas for LDL-C calculationAna Vujovic, Jelena Kotur-Stevuljevic, Slavica Spasic, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 24, 2017
Preanalytical and analytical challenges in gas chromatographic determination of cholesterol synthesis and absorption markersTamara Gojkovic, Sandra Vladimirov, Vesna Spasojevic-Kalimanovska, et al.
Clinical Biochemistry|February 16, 2011
Cox proportional hazard model analysis of survival in end-stage renal disease patients with small-sized high-density lipoprotein particlesJelena Vekic, Aleksandra Zeljkovic, Natasa Bogavac-Stanojevic, et al.
Clinical Chemistry and Laboratory Medicine|October 9, 2016
Can non-cholesterol sterols and lipoprotein subclasses distribution predict different patterns of cholesterol metabolism and statin therapy response?Tamara Gojkovic, Sandra Vladimirov, Vesna Spasojevic-Kalimanovska, et al.
Clinical Biochemistry|February 8, 2018
Effects of co-existing autoimmune diseases on serum lipids and lipoprotein subclasses profile in paediatric patients with type 1 diabetes mellitusDragana Bojanin, Tatjana Milenkovic, Jelena Vekic, et al.
Metabolites|January 21, 2023
The Role of Advanced Glycation End Products on DyslipidemiaJelena Vekic, Sanja Vujcic, Biljana Bufan, et al.
Clinical Chemistry and Laboratory Medicine|October 13, 2006
Paraoxonase-1 (PON1) activity, but not PON1(Q192R) phenotype, is a predictor of coronary artery disease in a middle-aged Serbian populationJelena Kotur-Stevuljevic, Slavica Spasic, Aleksandra Stefanovic, et al.
Pageof 7